LNTH compared with BBIO: revenue, margins and what each company keeps, and the suppliers and customers both name

LNTHLantheus Holdings, Inc.

Mkt capRevenueRevenue

BBIOBridgeBio Pharma, Inc.

Mkt capRevenueRevenue

Compare

LNTHLantheus Holdings, Inc.

BBIOBridgeBio Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LNTH

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±4.2%▼−0.44%×0.10

Q2 FY26±4.6%▼−0.42%×0.09

May 7 '26±10.5%▲+5.63%×0.53

Q1 FY26±13.1%▼−0.38%×0.03

BBIO

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±10.2%▲+5.97%×0.59

Q2 FY26±6.9%▼−1.15%×0.16

= impliedLNTH realized, solidBBIO realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

May 8 '26

±7.4%

▼−0.09%

×0.01

Q1 FY26±10.6%▼−2.59%×0.25

LNTHLantheus Holdings, Inc.

100.61▼−0.09%· post 100.60

Mkt cap$6.6BRevenue$390MQ3 FY26Revenue$1.5BFY24

BBIOBridgeBio Pharma, Inc.

74.270.00%· post 74.40

ClosedNov 6 '26

Mkt cap$14.5BRevenue$353MQ3 FY26Revenue$502MFY25

Compare

ClosedNov 6 '26

LNTHLantheus Holdings, Inc.

BBIOBridgeBio Pharma, Inc.

100.61▼−0.09%post 100.60

Price

74.270.00%post 74.40

$6.6B

Mkt cap

$14.5B

Q3 FY26$390M

Revenue

$353MQ3 FY26

FY24$1.5B

Revenue

$502MFY25

LNTH100.61▼−0.09%vsBBIO74.270.00%ClosedNov 6 '26